We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Pfizer, Qualcomm, Philip Morris International, Freeport-McMoRan and FedEx
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 1, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer Inc. (PFE - Free Report) , QUALCOMM Incorporated (QCOM - Free Report) , Philip Morris International Inc. (PM - Free Report) , Freeport-McMoRan Inc. (FCX - Free Report) and FedEx Corporation (FDX - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Stocks Reports for Pfizer, Qualcomm and Philip Morris
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer, Qualcomm, and Philip Morris International. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Pfizer have underperformed the Zacks Large Cap Pharmaceuticals industry in the year-to-date period (+8.2% vs. +10.7%). The Zacks analyst believes that the Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company, paving way for better revenue growth in the future.
Meanwhile, its COVID-19 vaccine candidate has also been approved for emergency use in several countries. Furthermore, a sustainable pipeline with multiple late-stage programs is expected to drive revenue growth. However, currency headwinds and pricing pressure are key top-line headwinds.
Qualcomm's shares have lost -5.3% over the last six months against the Zacks Wireless Equipment industry's gain of +5%. The Zacks analyst believes that Qualcomm is benefiting from a robust demand for smartphones globally and its ability to increase the scale of non-handset revenues.
Further, more than 700 5G designs position the company well to gain from solid 5G traction with greater long-term visibility. The chip maker is also focused on retaining its market leadership with innovative product launches. However, stiff competition from low-cost chip manufacturers remains a concern. Its margins have also declined due to high research and development expenses.
Shares of Philip Morris have gained +12.4% in the past three months against the Zacks Tobacco industry's gain of +3.3%. The Zacks analyst believes that the company has been benefiting from its pricing power, which continued to aid its first-quarter 2021 results.
Additionally, strength in its heated tobacco segment has consistently driven revenues. The segment has been gaining from the rising popularity of IQOS devices. However, cigarette volumes have been soft for a while due to rising health consciousness and stern regulations. Moreover, the company does not expect a near-term recovery in the duty-free business due to travel-related uncertainties amid the pandemic.
Other noteworthy reports we are featuring today include Freeport-McMoRan and FedEx.
Bitcoin, Like the Internet Itself, Could Change Everything
Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the "Internet of Money" and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we're still in the early stages of this technology, and as it grows, it will create several investing opportunities.
Zacks' has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Pfizer, Qualcomm, Philip Morris International, Freeport-McMoRan and FedEx
For Immediate Release
Chicago, IL – July 1, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer Inc. (PFE - Free Report) , QUALCOMM Incorporated (QCOM - Free Report) , Philip Morris International Inc. (PM - Free Report) , Freeport-McMoRan Inc. (FCX - Free Report) and FedEx Corporation (FDX - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Stocks Reports for Pfizer, Qualcomm and Philip Morris
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer, Qualcomm, and Philip Morris International. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Pfizer have underperformed the Zacks Large Cap Pharmaceuticals industry in the year-to-date period (+8.2% vs. +10.7%). The Zacks analyst believes that the Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company, paving way for better revenue growth in the future.
Meanwhile, its COVID-19 vaccine candidate has also been approved for emergency use in several countries. Furthermore, a sustainable pipeline with multiple late-stage programs is expected to drive revenue growth. However, currency headwinds and pricing pressure are key top-line headwinds.
(You can read the full research report on Pfizer here >>>)
Qualcomm's shares have lost -5.3% over the last six months against the Zacks Wireless Equipment industry's gain of +5%. The Zacks analyst believes that Qualcomm is benefiting from a robust demand for smartphones globally and its ability to increase the scale of non-handset revenues.
Further, more than 700 5G designs position the company well to gain from solid 5G traction with greater long-term visibility. The chip maker is also focused on retaining its market leadership with innovative product launches. However, stiff competition from low-cost chip manufacturers remains a concern. Its margins have also declined due to high research and development expenses.
(You can read the full research report on Qualcomm here >>>)
Shares of Philip Morris have gained +12.4% in the past three months against the Zacks Tobacco industry's gain of +3.3%. The Zacks analyst believes that the company has been benefiting from its pricing power, which continued to aid its first-quarter 2021 results.
Additionally, strength in its heated tobacco segment has consistently driven revenues. The segment has been gaining from the rising popularity of IQOS devices. However, cigarette volumes have been soft for a while due to rising health consciousness and stern regulations. Moreover, the company does not expect a near-term recovery in the duty-free business due to travel-related uncertainties amid the pandemic.
(You can read the full research report on Philip Morris here >>>)
Other noteworthy reports we are featuring today include Freeport-McMoRan and FedEx.
Bitcoin, Like the Internet Itself, Could Change Everything
Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the "Internet of Money" and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we're still in the early stages of this technology, and as it grows, it will create several investing opportunities.
Zacks' has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.
See 3 crypto-related stocks now >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.